Gosselies
Belgium
7
2019-01-24
7
2020-06-16
These are the the leading inventors for applications assigned to Ogeda SA:
Ogeda SA based in Gosselies, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof
#2 | 2018-07-12 ✅ Patent 10,544,150 granted on 2020-01-28NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders
#3 | 2017-10-05 ✅ Patent 10,017,468 granted on 2018-07-10Substituted pyrrolidines as G-protein coupled receptor 43 agonists
#4 | 2017-02-02 ✅ Patent 10,065,961 granted on 2018-09-04Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof
#5 | 2015-11-05 ✅ Patent 10,065,960 granted on 2018-09-04NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders
#6 | 2014-12-18 ✅ Patent 9,926,325 granted on 2018-03-27NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders
#7 | 2013-01-24 ✅ Patent 9,695,120 granted on 2017-07-04Substituted pyrrolidines as G-protein coupled receptor 43 agonists
Also check out Ogeda SA's (Gosselies, Belgium) applicant profile with 7 patent applications submitted.
525183 ⎘